Allergan Must Face FCA Claims Over Dementia Drug Patents
Allergan Must Face FCA Claims Over Dementia Drug Patents … to dodge a False Claims Act lawsuit Friday, finding the patent attorney behind the suit …
PATENT NEWS
-
In: PATENT NEWS
-
In: PATENT NEWS
Allergan Must Face FCA Claims Over Dementia Drug Patents – Law360
Allergan Must Face FCA Claims Over Dementia Drug Patents Law360
-
In: PATENT NEWS
Patent Attorney or Agent – Law Firm – Kansas City
Performing “prior art” searching to locate patents and other technical information relevant to a client’s invention; Preparing patent applications; Analyzing …
-
In: PATENT NEWS
Fed. Circ. OKs ‘Bling It On’ IP Win Over Sparkly Pepper Sprays
Skyline, in response, asserted counterclaims of unfair competition under the Lanham Act and common law, tortious interference and business …
-
In: PATENT NEWS
The Patent Law Office PC announces a limited offer for fixed fee utility patent applications
Clients use the firm’s advanced patent filing and support system as featured in the Intellectual Property Expert Guide 2021. AI has transformed how …
-
In: PATENT NEWS
Del. Chief Urges Creativity When Litigating Patent Eligibility – Law360
Del. Chief Urges Creativity When Litigating Patent Eligibility Law360
-
In: PATENT NEWS
Del. Chief Urges Creativity When Litigating Patent Eligibility
During a panel discussion at the Annual Berkeley-Stanford Advanced Patent Law Institute, Chief U.S. District Judge Leonard Stark said he’d consider …
-
In: PATENT NEWS
Shell Unit’s Failed Atty DQ Bid Faulted For Lack Of Research
While the employee, Andrei Filippov, did sign over his rights to at least one of those other patents, it was distinct from the ‘819 patent, the judge said. ” …
-
In: PATENT NEWS
The Patent Law Office PC announces a limited offer for fixed fee utility patent applications – PR Web
The Patent Law Office PC announces a limited offer for fixed fee utility patent applications PR Web
-
In: PATENT NEWS
Fed. Circ. Hints At Remand In Dispute Over Evolved’s Patent – Law360
Fed. Circ. Hints At Remand In Dispute Over Evolved’s Patent Law360